{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:49:16Z","timestamp":1781542156231,"version":"3.54.5"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2321-B-002-024"],"award-info":[{"award-number":["107-2321-B-002-024"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>H6 avian influenza viruses (AIVs) have a worldwide distribution, and they pose a potential concern for public health. In Taiwan, H6 AIVs have circulated in domestic chickens for more than 40 years, and certain strains have crossed the species barrier to infect mammals. With the goal of containing the disease, there is a pressing need to develop a safe and effective vaccine for pandemic preparedness. In this study, we prepared a virus-like particle (VLP) that consisted of the hemagglutinin (HA) and matrix protein 1 (M1) derived from a H6 AIV as a vaccine antigen, and we examined the immunogenicity and protective efficacy when combined with an adjuvant in a chicken model. Full-length HA and M1 protein genes were cloned and expressed using a baculovirus expression system, and VLPs were purified from the supernatant of insect cell cultures. We performed nanoparticle-tracking analysis and transmission electron microscopy to validate that the particle structure and properties resembled the native virions. In animal experiments, specific-pathogen-free chickens that received the H6 VLPs in combination with an adjuvant showed superior H6N1 virus-specific serum IgG and hemagglutination-inhibition antibody responses, which lasted more than 112 days. Following the H6N1 viral challenge, the vaccinated chickens showed reduced viral replication in the lungs, kidneys and conjunctival\/cloacal shedding. The antibodies induced in the chickens by the vaccine were able to cross-react with the H6N1 human isolate and drifted avian H6N1 isolates. In summary, the H6 VLP vaccine elicited superb immunogenicity in vivo, and the use of an adjuvant further enhanced the antiviral protective efficacy. This vaccine formulation could potentially be used to manage H6 influenza virus infections in chickens.<\/jats:p>","DOI":"10.3390\/vaccines8030465","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T09:21:51Z","timestamp":1598001711000},"page":"465","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-Influenza Protective Efficacy of a H6 Virus-Like Particle in Chickens"],"prefix":"10.3390","volume":"8","author":[{"given":"Wan-Zhen","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chi","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4244-7842","authenticated-orcid":false,"given":"Shu-Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chih","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-3420","authenticated-orcid":false,"given":"Hui-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., and Gomez, J. (2013). New world bats harbor diverse influenza A viruses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003657"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Munster, V.J., Baas, C., Lexmond, P., Waldenstr\u00f6m, J., Wallensten, A., Fransson, T., Rimmelzwaan, G.F., Beyer, W.E., Schutten, M., and Olsen, B. (2007). Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030061"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/JVI.03292-13","article-title":"H6 influenza viruses pose a potential threat to human health","volume":"88","author":"Wang","year":"2014","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12985-017-0680-1","article-title":"New H6 influenza virus reassortment strains isolated from Anser fabalis in Anhui Province, China","volume":"14","author":"Ge","year":"2017","journal-title":"Virol. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1128\/JVI.01206-08","article-title":"Avian influenza h6 viruses productively infect and cause illness in mice and ferrets","volume":"82","author":"Santos","year":"2008","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00705-014-2058-7","article-title":"Experimental infection of dogs with H6N1 avian influenza A virus","volume":"159","author":"Cheng","year":"2014","journal-title":"Arch. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1637\/7640-050106R.1","article-title":"Genetic and pathogenic characterization of H6N1 avian influenza viruses isolated in Taiwan between 1972 and 2005","volume":"50","author":"Lee","year":"2006","journal-title":"Avian Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3201\/eid2112.141229","article-title":"Influenza A (H6N1) virus in dogs, Taiwan","volume":"21","author":"Lin","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(13)70221-2","article-title":"Human infection with avian influenza A H6N1 virus: An epidemiological analysis","volume":"1","author":"Wei","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1017\/S0950268815000394","article-title":"Serological comparison of antibodies to avian influenza viruses, subtypes H5N2, H6N1, H7N3 and H7N9 between poultry workers and non-poultry workers in Taiwan in 2012","volume":"143","author":"Huang","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1080\/14760584.2019.1704262","article-title":"Advances in influenza virus-like particles bioprocesses","volume":"18","author":"Durous","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","article-title":"Engineering virus-like particles as vaccine platforms","volume":"18","author":"Frietze","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: A review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mohsen, M., Gomes, A., Vogel, M., and Bachmann, M. (2018). Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system. Vaccines, 6.","DOI":"10.3390\/vaccines6030037"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Mellado","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1637\/6093","article-title":"Experimental selection of virus derivatives with variations in virulence from a single low-pathogenicity H6N1 avian influenza virus field isolate","volume":"47","author":"Wang","year":"2003","journal-title":"Avian Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27870","DOI":"10.1038\/srep27870","article-title":"Nasal commensal Staphylococcus epidermidis counteracts influenza virus","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hu, C.J., Chien, C.Y., Liu, M.T., Fang, Z.S., Chang, S.Y., Juang, R.H., Chang, S.C., and Chen, H.W. (2017). Multi-antigen avian influenza a (H7N9) virus-like particles: Particulate characterizations and immunogenicity evaluation in murine and avian models. BMC Biotechnol., 17.","DOI":"10.1186\/s12896-016-0321-6"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vetmic.2009.09.064","article-title":"Detection of H6 influenza antibody by blocking enzyme-linked immunosorbent assay","volume":"142","author":"Chen","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_22","unstructured":"OIE (2020, June 20). Chapter 2.3.4. Avian Influenza (Infection with Avian Influenza Viruses). Available online: http:\/\/www.oie.int\/fileadmin\/Home\/fr\/Health_standards\/tahm\/2.03.04_AI.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1386-6532(03)00122-7","article-title":"Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement","volume":"29","author":"Ward","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"39953","DOI":"10.1021\/acsami.7b09931","article-title":"Targeting and Enrichment of Viral Pathogen by Cell Membrane Cloaked Magnetic Nanoparticles for Enhanced Detection","volume":"9","author":"Chen","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.2147\/IJN.S185806","article-title":"Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection","volume":"13","author":"Hu","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1099\/vir.0.019935-0","article-title":"Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase","volume":"91","author":"Lai","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.vaccine.2016.02.011","article-title":"Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses","volume":"34","author":"Kapczynski","year":"2016","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/pbi.13219","article-title":"Efficacy of a plant-produced virus-like particle vaccine in chickens challenged with Influenza A H6N2 virus","volume":"18","author":"Smith","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/138945007782151360","article-title":"Protein N-glycosylation in the baculovirus-insect cell system","volume":"8","author":"Shi","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2015.10.019","article-title":"A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses","volume":"126","author":"Yang","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","article-title":"Influenza A virus cell entry, replication, virion assembly and movement","volume":"9","author":"Dou","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nsb0397-239","article-title":"Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1","volume":"4","author":"Sha","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Safo, M.K., Musayev, F.N., Mosier, P.D., Zhou, Q., Xie, H., and Desai, U.R. (2014). Crystal structures of influenza A virus matrix protein M1: Variations on a theme. PloS ONE, 9.","DOI":"10.2210\/pdb4pus\/pdb"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1373.024","article-title":"SEPPIC vaccine adjuvants for poultry","volume":"1081","author":"Dupuis","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/hv.7.4.13845","article-title":"Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability","volume":"7","author":"Tan","year":"2011","journal-title":"Hum. Vaccines"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2016.12.001","article-title":"Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens","volume":"501","author":"Pushko","year":"2017","journal-title":"Virology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sunwoo, S.-Y., Schotsaert, M., Morozov, I., Davis, A., Li, Y., Lee, J., McDowell, C., Meade, P., Nachbagauer, R., and Garc\u00eda-Sastre, A. (2018). A universal influenza virus vaccine candidate tested in a pig vaccination-infection model in the presence of maternal antibodies. Vaccines, 6.","DOI":"10.3390\/vaccines6030064"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00018-10","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture","volume":"9","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1586\/erv.12.70","article-title":"Virus-like particles as universal influenza vaccines","volume":"11","author":"Kang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1016\/j.vaccine.2011.03.067","article-title":"H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/465\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:04:45Z","timestamp":1760177085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030465"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030465","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]}}}